Nasopharyngeal oxygen therapy, the delivery of supplementary oxygen into the nasopharynx via a fine catheter placed through the nose, is a simple technique used in postoperative anaesthetic care units and paediatric intensive care, but never described in the setting of adult intensive care. In a prospective crossover design, we compared nasopharyngeal oxygen therapy with semi-rigid plastic mask (Hudson Mask) in 50 unintubated adult patients receiving supplemental oxygen. We measured oxygen flow rate to achieve cutaneous saturations 93 to 96%, and patient comfort by visual analogue score. Nasopharyngeal oxygen therapy consumed significantly less oxygen than mask administration (3.0±0.9 vs 6.7±2.1 l/min, P<0.001) and was associated with significantly higher comfort than the mask (7.5± 1.6 cm vs 5.2±1.8, P<0.001).
The majority of patients admitted to the intensive care unit (ICU) require some type of oxygen supplement. In spite of its ubiquity of use, oxygen is often poorly prescribed, administered and monitored 1 . The choice of method of oxygen supplementation can be difficult when the range of options is wide and the benefit of any particular method unproven 2 . Few of the basic techniques of oxygen supplementation have been subjected to detailed measurement.
Nasopharyngeal oxygen administration involves the placement of a fine bore oxygen catheter through the nose into the nasopharynx behind the soft palate. It is used in post-anaesthetic recovery units and in paediatric intensive care 3 . To the best of our knowledge there has been no published research on the use of nasopharyngeal oxygen therapy in adults. We hypothesized that nasopharyngeal oxygen could be a beneficial addition to the range of oxygen supplements available to adult patients in intensive care. Therefore we performed a prospective crossover study to compare oxygen supplementation via nasopharyngeal oxygen catheter and semi-rigid plastic mask (Hudson Mask) in critically ill adults. The primary outcome measures were oxygen flow to achieve adequate oxygenation and subjective comfort through the use of a visual analogue scale (VAS).
MATERIALS AND METHODS
Institutional ethics approval was obtained and patients or guardians gave informed consent. Nonintubated patients admitted to ICU between February and August 2002 were considered. Eligible patients were spontaneously breathing, required supplemental oxygen, and had an arterial line in situ. Cardiac surgical patients usually met the inclusion criteria within twelve hours of admission. General ICU patients were included whenever they satisfied the entry criteria. We excluded patients who had facial or skull fractures or bleeding disorders. Sixtyfour patients were invited to participate, of whom eight declined. We were unable to pass the nasopharyngeal oxygen catheter in six. Fifty patients (38 male, 12 female) completed the study. Their mean age was 70 years (SD 9), mean Apache II score 20.7 (SD 4.0). Forty were post cardiac surgery and ten came from the general ICU.
A size 10 French oxygen catheter was inserted according to WHO recommendations 4 , i.e. to a depth equal to the distance between the ala nasi and the tragus. This should bring the tip of the catheter to lie just behind the soft palate. Non-humidified oxygen flow was titrated to achieve a cutaneous oxygen saturation (SaO 2 ) of 93-96%, first with Hudson Mask (minimum flow 6 litres per minute to prevent carbon dioxide re-breathing) and second with nasopharyngeal oxygen (maximum flow 4 l/min to prevent drying of mucous membranes). After 10 minutes at steady state with each method, arterial blood gas (Radiometer ABL625), respiratory rate, oxygen flow rate, SaO 2 , and patient acquired VAS were recorded.
Our primary outcome measures were oxygen flow rate, in litres per minute, and comfort level by visual analogue scale (VAS, 0 cm=most uncomfortable through 10 cm=most comfortable). Withinpatient parametric data was compared using paired t-tests (SYSTAT 10.2 Software, Richmond CA, U.S.A.) with no adjustment for multiple comparisons. Results are presented as means and mean differences with standard deviation.
RESULTS

DISCUSSION
We found that nasopharyngeal administration required less than half the oxygen flow to maintain equivalent oxygenation compared with mask administration and that the nasopharyngeal technique was significantly more comfortable than the mask method. There was no significant difference between the two techniques with respect to the other studied variables (respiratory rate, P a CO 2 and HCO 3 -).
There were some limitations in our study design. First, the order of measurement (mask, then nasopharyngeal oxygen) was fixed, not randomized as would be desirable. There is a possibility of time and order related effects in crossover studies 5 , but we had to ensure that the patients could be adequately oxygenated with the mask before testing the nasopharyn-geal technique. Second, titration of oxygen flow rate against cutaneous oxygen saturation is potentially inaccurate but multiple blood gas analyses were not practical or justifiable. Third, although APACHE II scores are widely used, they have limitations, especially in cardiac surgical patients.
The apparent invasiveness of the procedure was initially disconcerting for staff and caused some patient refusals (8/64=12%). We were unable to successfully place the catheter in six patients (9.4%). These problems were more than offset by the benefits of nasopharyngeal oxygen, namely decreased oxygen use, a quieter clinical environment, easier communication between staff and patient, decreased claustrophobia and the ability to supplement oxygen during meals.
As outlined by Shann 3 , there are several caveats with the use of nasopharyngeal oxygen: -to ensure tip of catheter is correctly situated in the pharynx by inspection, -to remove and clean catheter every 12 to 24 hours to reduce risk of obstruction, -to avoid excessive oxygen flow rates, and -to bubble humidify the oxygen where possible.
In conclusion, we have shown that nasopharyngeal catheter administration of oxygen provides adequate oxygenation in selected ICU patients. The technique consumes less oxygen and provides greater patient comfort than the Hudson mask. We foresee broader applications for nasopharyngeal oxygen administration both in ICU and beyond, where oxygen supply is expensive or limited (developing countries or remote locations) or where the increased comfort and decreased claustrophobia may be clinically important (anxious, mask-intolerant or agitated patients). Finally, it may be a useful way to increase the inspired oxygen concentration during mask continuous positive airway pressure (CPAP), but this needs further research. 
